// COMPANY
Electra Therapeutics
SECTOR BIOTECHMENTIONS 1LAST SEEN SEPTEMBER 14, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·Axios Pro Rata·SEPTEMBER 14, 2026
“Electra Therapeutics, an SF-based biotech... set IPO terms to 21.67m shares at $14-$16. It would have a $917m market cap at the midpoint.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.